Generic name |
abatacept |
---|---|
Strength |
250 mg per 15 mL |
Form |
intravenous infusion vial |
Special Authority criteria |
Approval period |
---|---|
For the treatment of moderate to severe active polyarticular Juvenile Idiopathic Arthritis (pJIA) for patients 6 years and older, who, due to intolerance or lack of efficacy, have not adequately responded to methotrexate. |
1 year |